Hormonal
Probiotic therapy significantly reduces liver aminotransferases (ALT, AST), total cholesterol, TNF-α, and insulin resistance (HOMA-IR) in patients with nonalcoholic fatty liver disease (NAFLD).
If you have been diagnosed with fatty liver (NAFLD), adding a probiotic supplement (specifically strains like Lactobacillus or Bifidobacterium) for at least 8 weeks may help lower liver enzymes, cholesterol, and improve insulin sensitivity. This is not a replacement for diet and exercise, but a potential supportive therapy to discuss with your doctor.
Probiotic therapies can reduce liver aminotransferases, total-cholesterol, TNF-α and improve insulin resistance in NAFLD patients.
Why this rating
Based on a meta-analysis of 4 randomized controlled trials (RCTs) with moderate sample sizes (134 patients total) and generally high methodological quality (Jadad score ≥ 4).
Source
Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
Han Ma · World Journal of Gastroenterology · 2013
DOI 10.3748/wjg.v19.i40.6911
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →